ERBB2 and breast carcinoma: We first identified 2 published data sets (41, 42) of HER2+ (i.e., ERBB2-overexpressing) breast cancer cell lines that were treated with growth factors (Supplemental Figure 1A; supplemental material available online with this article; https://doi.org/10.1172/JCI189900DS1).